Rossari Net Receivables from 2010 to 2025
| ROSSARI Stock | 831.90 6.45 0.78% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 4.9 B | Current Value 5.1 B | Quarterly Volatility 1.7 B |
Check Rossari Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rossari Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 729.2 M, Interest Expense of 233.9 M or Total Revenue of 22.1 B, as well as many indicators such as . Rossari financial statements analysis is a perfect complement when working with Rossari Biotech Valuation or Volatility modules.
Rossari | Net Receivables |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Rossari Stock
Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.